Angelman, Rett, and Prader-Willi Syndromes Consortium

NEPTUNE: Nephrotic Syndrome Rare Disease Clinical Research Network

Autonomic Rare Diseases Clinical Research Consortium

Porphyrias Consortium

Brain Vascular Malformation Consortium

Primary Immune Deficiency Treatment Consortium (PIDTC)

Chronic Graft Versus Host Disease Consortium (cGHVD)

Rare Kidney Stone Consortium

Genetic Diseases of Mucociliary Clearance Consortium

Salivary Gland Carcinomas Consortium

Inherited Neuropathies Consortium

STAIR: Sterol and Isoprenoid Diseases Consortium

Lysosomal Disease Network

Urea Cycle Disorders Consortium

North American Mitochondrial Disease Consortium

Vasculitis Clinical Research Consortium

Join the Contact Registry

 

 

 

 

 

Angelman, Rett, and Prader-Willi Syndromes Consortium

Autonomic Rare Diseases Clinical Research Consortium

Brain Vascular Malformation Consortium

Chronic Graft Versus Host Disease Consortium (cGHVD)

Genetic Diseases of Mucociliary Clearance Consortium

Inherited Neuropathies Consortium

Lysosomal Disease Network

North American Mitochondrial Disease Consortium

NEPTUNE: Nephrotic Syndrome Rare Disease Clinical Research Network

Porphyrias Consortium

Primary Immune Deficiency Treatment Consortium (PIDTC)

Rare Kidney Stone Consortium

Salivary Gland Carcinomas Consortium

STAIR: Sterol and Isoprenoid Diseases Consortium

Urea Cycle Disorders Consortium

Vasculitis Clinical Research Consortium


About the RDCRN

The Rare Diseases Clinical Research Network (RDCRN) was established by the Office of Rare Diseases Research of (NCATS), National Institutes of Health (NIH) to develop research studies for rare diseases, and to encourage cooperative partnerships among researchers at over 150 clinical centers around the world. This increased cooperation may lead to discoveries that will help treat and perhaps prevent these rare diseases, as well as produce medical advances that will benefit the population in general. The Rare Diseases Clinical Research Network is comprised of a Data Management and Coordinating Center and 17 consortia studying over 200 rare diseases. More About the RDCRN >


NIH does not endorse or recommend any commercial products, processes, or services. The views expressed in written materials or publications do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government. Read Disclaimer >